Wide Ranks

IKNA

Ikena Oncology, Inc.

1.69

Top Statistics
Market Cap 81 M Forward PE -2.01 Revenue Growth 0.00 %
Current Ratio 15.32 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA 0.7560 Enterprise / Revenue -72.96 Price To Sales Trailing12 Months 123.76
Profitability
Profit Margins 0.00 % Operating Margins -9755.24 %
Balance Sheet
Total Cash 138 M Total Cash Per Share 2.86 Total Debt 8 M
Total Debt To Equity 6.25 Current Ratio 15.32 Book Value Per Share 2.78
All Measures
Short Ratio 139.00 % Message Board Id finmb_302325481 Shares Short Prior Month 147782
Return On Equity -0.3709 City Boston Uuid 91b1e3b2-6a3b-3cff-83da-6bebdfb084db
Previous Close 1.71 First Trade Date Epoch Utc 1 B Book Value 2.78
Beta 0.4850 Total Debt 8 M Volume 97050
Price To Book 0.6075 Fifty Two Week Low 1.22 Total Cash Per Share 2.86
Total Revenue 659000 Shares Short Previous Month Date 1 B Target Median Price 3.00
Max Age 86400 Sand P52 Week Change 0.3133 Operating Margins -9755.24 %
Target Mean Price 3.00 Net Income To Common -59599000 Short Percent Of Float 0.0021
Implied Shares Outstanding 48 M Trailing Peg Ratio None Last Fiscal Year End 1 B
Average Daily Volume10 Day 80300 Average Volume10days 80300 Total Cash 138 M
Next Fiscal Year End 1 B Revenue Per Share 0.0140 Held Percent Insiders 0.1049
Trailing PE 0.0000 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 1.71 Target Low Price 2.00 Gmt Off Set Milliseconds -18000000
Fifty Day Average 1.71 Open 1.75 Free Cashflow -43967376
State MA Dividend Yield 0.00 % Return On Assets -0.2206
Time Zone Short Name EST Trailing Eps -1.23 Day Low 1.69
Address1 645 Summer Street Shares Outstanding 48 M Price Hint 4
Target High Price 4.00 Website https://ikenaoncology.com 52 Week Change 0.1655
Average Volume 54192 Forward Eps -0.8500 Recommendation Key none
Compensation As Of Epoch Date 1 B Quick Ratio 1493.90 % Is_sp_500 False
Regular Market Day High 1.75 Profit Margins 0.00 % Debt To Equity 6.25
Fifty Two Week High 2.32 Day High 1.75 Shares Short 82556
Regular Market Open 1.75 Industry Key biotechnology Earnings Growth 0.00 %
Enterprise To Revenue -72.96 Revenue Growth 0.00 % Shares Percent Shares Out 0.0017
Operating Cashflow -61563000 Currency USD Time Zone Full Name America/New_York
Market Cap 81 M Is_nasdaq_100 False Zip 02210
Quote Type EQUITY Industry Biotechnology Long Name Ikena Oncology, Inc.
Regular Market Day Low 1.69 Held Percent Institutions 0.6358 Current Price 1.69
Address2 Suite 101 Enterprise To Ebitda 0.7560 Financial Currency USD
Current Ratio 15.32 Industry Disp Biotechnology Number Of Analyst Opinions 2
Country United States Float Shares 13 M Two Hundred Day Average 1.59
Enterprise Value -48082792 Price To Sales Trailing12 Months 123.76 Forward PE -2.01
Regular Market Volume 97050 Ebitda -63581000 Exchange NGM
Go to Yahoo Finance Go to Seeking Alpha 
Ikena Oncology, Inc. operates as an oncology company that develops differentiated therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the United States.

Its lead program is IK-930, an internally discovered, oral, TEAD1-selective, small molecule inhibitor of the Hippo pathway.

The company also develops IK-595, a molecular glue designed to trap MEK and RAF in an inactive complex.

Ikena Oncology, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.